Bahl & Gaynor’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,384
Closed -$314K 333
2025
Q2
$314K Hold
5,384
﹤0.01% 305
2025
Q1
$267K Hold
5,384
﹤0.01% 321
2024
Q4
$241K Sell
5,384
-384
-7% -$18.2K ﹤0.01% 318
2024
Q3
$277K Hold
5,768
﹤0.01% 319
2024
Q2
$294K Sell
5,768
-334
-5% -$18.3K ﹤0.01% 307
2024
Q1
$331K Buy
6,102
+276
+5% +$14.4K ﹤0.01% 308
2023
Q4
$328K Buy
5,826
+58
+1% +$3.28K ﹤0.01% 303
2023
Q3
$356K Sell
5,768
-192
-3% -$12.1K ﹤0.01% 293
2023
Q2
$352K Hold
5,960
﹤0.01% 302
2023
Q1
$440K Hold
5,960
﹤0.01% 292
2022
Q4
$435K Hold
5,960
﹤0.01% 292
2022
Q3
$497K Hold
5,960
﹤0.01% 273
2022
Q2
$475K Hold
5,960
﹤0.01% 281
2022
Q1
$620K Hold
5,960
﹤0.01% 278
2021
Q4
$448K Hold
5,960
﹤0.01% 294
2021
Q3
$386K Buy
+5,960
New +$364K ﹤0.01% 299

Other funds holding NTR

Bahl & Gaynor's NTR Position: Q3 2025 in Review

Bahl & Gaynor sold out of Nutrien (NTR) in Q3 2025, closing a stake of 5,384 shares — an estimated $314K sold.

Bahl & Gaynor first reported a position in NTR in Q3 2021 and held it in 16 quarters. The position peaked at $620K in Q1 2022. 646 funds tracked by Wall St. Rank hold NTR as of Q3 2025.

  • Bahl & Gaynor reported no remaining Nutrien position as of Q3 2025 after selling out during the quarter.
  • Bahl & Gaynor sold 5,384 Nutrien shares in Q3 2025, an estimated $314K.
  • Bahl & Gaynor first reported a position in Nutrien in Q3 2021 and held it in 16 quarters.
  • Bahl & Gaynor's Nutrien position peaked at $620K in Q1 2022.
  • 646 funds tracked by Wall St. Rank held Nutrien as of Q3 2025.

Based on Bahl & Gaynor's 13F filing for Q3 2025, filed 12 Nov 2025.